Hemorrhoidal Cream
NDC Package 0363-0641-18
Package Information
Hemorrhoidal Cream cream is -adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before applying cream. When first opening the tube, puncture foil seal with top end of cap. Apply externally or in the lower portion of the anal canal only. Apply to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement. This formulation utilizes a cream delivery system. Marketed by Walgreens, this product is identified by NDC 0363-0641 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 1293649 - glycerin 14.4 % / phenylephrine HCl 0.25 % / pramoxine HCl 1 % / white petrolatum 15 % Rectal Cream
- RxCUI: 1293649 - glycerin 144 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream
- RxCUI: 1293649 - glycerin 14.4 % / phenylephrine hydrochloride 0.25 % / pramoxine hydrochloride 1 % / white petrolatum 15 % Rectal Cream
Clinical Specifications
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Glycerol - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Glycerol - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0363 - Walgreens
- 0363-0641 - Hemorrhoidal Cream
- 0363-0641-18 - 1 TUBE in 1 PACKAGE / 51 g in 1 TUBE (0363-0641-19)
- 0363-0641 - Hemorrhoidal Cream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0363-0641). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0363-0641-18 identifies a specific commercial package of 1 tube in 1 package / 51 g in 1 tube (0363-0641-19) of Hemorrhoidal Cream, a human over the counter drug labeled by Walgreens. This cream is formulated for topical use and contains glycerin; petrolatum; phenylephrine hydrochloride; pramoxine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens on March 25, 2018. The current certification is valid through December 31, 2027.
How is this Walgreens product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363064118. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.